Theravance Biopharma, Inc. (TBPH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1134408,
    "name": "Theravance Biopharma, Inc.",
    "stock_name": "Theravance Biopharma, Inc.",
    "full_name": "Theravance Biopharma, Inc.",
    "name_url": "stocks-analysis/theravance-biopharma-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "18.70",
    "chg": 0.27,
    "chgp": "1.47%",
    "dir": 1,
    "prev_price": "18.43",
    "mcapval": "701.03",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "KYG8807B1068",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "662.46 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/theravance-biopharma-inc-1134408-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Theravance Biopharma Hits New 52-Week High of $18.96, Up 112.64%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/theravance-biopharma-hits-new-52-week-high-of-1896-up-11264-3693004",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TheravanceBioph_priceRelatedfactors_3693004.png",
        "date": "2025-11-12 16:14:00",
        "description": "Theravance Biopharma, Inc. achieved a new 52-week high of USD 18.96, reflecting strong performance in the pharmaceuticals sector. The company reported a 112.64% increase in stock performance over the past year and an 83.75% rise in net sales, supported by high institutional holdings and solid financial metrics."
      },
      {
        "title": "Theravance Biopharma Achieves Multibagger Status with 103.74% Stock Surge Over Past Year",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/theravance-biopharma-achieves-multibagger-status-with-10374-stock-surge-over-past-year-3692981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TheravanceBioph_multibagger_3692981.png",
        "date": "2025-11-12 15:26:56",
        "description": "Theravance Biopharma, Inc. has recently undergone a revision in its score, reflecting its impressive performance metrics and strong market position. The stock has outperformed the S&P 500 significantly over the past year and reported substantial growth in net sales and operating cash flow, indicating robust operational strength."
      },
      {
        "title": "Is Theravance Biopharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-theravance-biopharma-inc-technically-bullish-or-bearish-3673718",
        "imagepath": "",
        "date": "2025-11-05 11:23:26",
        "description": "As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The MACD is bullish on both weekly and monthly time frames, while Bollinger Bands also indicate a bullish stance on both time frames. However, the monthly RSI shows a bearish signal, and the KST is mildly bearish on the weekly but bullish monthly. Moving averages are bullish on the daily. Dow Theory reflects a mildly bullish stance on both weekly and monthly.\n\nIn terms of performance, Theravance Biopharma has outperformed the S&P 500 significantly year-to-date with a return of 56.75% compared to the S&P 500's 16.30%, and over the past year, it has returned 79.00% versus the S&P 500's 19.89%. Overall, the current technical stance is bullish, driven by strong MACD and Bollinger Bands indicators, despite some mixed signals from RSI and KST...."
      },
      {
        "title": "Theravance Biopharma Hits New 52-Week High of $15.34, Up 74.94%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/theravance-biopharma-hits-new-52-week-high-of-1534-up-7494-3671523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TheravanceBioph_priceRelatedfactors_3671523.png",
        "date": "2025-11-04 17:59:01",
        "description": "Theravance Biopharma, Inc. achieved a new 52-week high of USD 15.34 on November 3, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported significant growth in net sales and operating cash flow, alongside high institutional holdings, indicating robust operational fundamentals and a positive recovery trajectory."
      },
      {
        "title": "Is Theravance Biopharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-theravance-biopharma-inc-technically-bullish-or-bearish-3670896",
        "imagepath": "",
        "date": "2025-11-04 11:35:14",
        "description": "As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by bullish signals in both the weekly and monthly MACD, as well as bullish Bollinger Bands across the same time frames. The daily moving averages also indicate a bullish trend. However, the monthly RSI shows a bearish signal, and the KST is mildly bearish on the weekly but bullish on the monthly, which suggests some mixed signals. \n\nIn terms of performance, the stock has outperformed the S&P 500 significantly over the past year, returning 84.71% compared to the S&P 500's 19.89%. Over the year-to-date period, the stock has returned 61.74% versus the S&P 500's 16.30%...."
      },
      {
        "title": "Is Theravance Biopharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-theravance-biopharma-inc-technically-bullish-or-bearish-3666501",
        "imagepath": "",
        "date": "2025-11-03 11:34:51",
        "description": "As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by daily moving averages and positive signals from Bollinger Bands and KST on both weekly and monthly time frames. However, the MACD indicates a mildly bearish position on the weekly chart, and the RSI shows a bearish signal on the monthly chart. Dow Theory presents a mildly bearish view on the weekly but is mildly bullish monthly. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past year with a return of 77.91% compared to the S&P 500's 19.89%, although it has underperformed over the 3-year and 5-year periods...."
      },
      {
        "title": "Is Theravance Biopharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-theravance-biopharma-inc-technically-bullish-or-bearish-3664616",
        "imagepath": "",
        "date": "2025-11-02 11:19:10",
        "description": "As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by daily moving averages and bullish signals from Bollinger Bands and KST across both weekly and monthly time frames. However, the MACD is mildly bearish on the weekly and bullish on the monthly, while the RSI shows a bearish signal on the monthly. Dow Theory indicates a mildly bearish weekly trend but a mildly bullish monthly trend. \n\nIn terms of performance, the stock has outperformed the S&P 500 significantly year-to-date with a return of 55.79% compared to 16.30%, and over the past year with 77.91% against 19.89%. However, over the longer term, the 3-year and 5-year returns are lagging behind the S&P 500. Overall, the current technical stance is bullish but with some mixed signals in the indicators...."
      },
      {
        "title": "Is Theravance Biopharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-theravance-biopharma-inc-technically-bullish-or-bearish-3651480",
        "imagepath": "",
        "date": "2025-10-28 11:44:18",
        "description": "As of 24 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, and the moving averages are bullish on a daily basis. Additionally, the Bollinger Bands are bullish weekly and mildly bullish monthly, while the KST is bullish in both time frames. However, the RSI shows a bearish signal on the monthly chart, indicating some caution. The Dow Theory is mildly bullish monthly but shows no trend weekly. The OBV is mildly bullish weekly but mildly bearish monthly, suggesting mixed volume trends. Overall, the strength of the bullish stance is supported by multiple indicators, despite some mixed signals. No multi-period return data is available for comparison with the S&P 500...."
      },
      {
        "title": "Is Theravance Biopharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-theravance-biopharma-inc-technically-bullish-or-bearish-3647934",
        "imagepath": "",
        "date": "2025-10-27 11:55:26",
        "description": "As of 24 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators from the MACD and KST on both weekly and monthly timeframes. The moving averages are also bullish on the daily timeframe. However, the RSI shows a bearish signal monthly, indicating some caution. The Bollinger Bands are bullish weekly and mildly bullish monthly, while the Dow Theory indicates a mildly bullish trend monthly. Overall, the strength of the bullish stance is supported by multiple indicators, despite some mixed signals from the RSI and OBV. Multi-period return data is not available for comparison with the S&P 500...."
      }
    ],
    "total": 25,
    "sid": "1134408",
    "stock_news_url": "https://www.marketsmojo.com/news/theravance-biopharma-inc-1134408"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Theravance Biopharma Hits New 52-Week High of $18.96, Up 112.64%

2025-11-12 16:14:00

Theravance Biopharma, Inc. achieved a new 52-week high of USD 18.96, reflecting strong performance in the pharmaceuticals sector. The company reported a 112.64% increase in stock performance over the past year and an 83.75% rise in net sales, supported by high institutional holdings and solid financial metrics.

Theravance Biopharma Achieves Multibagger Status with 103.74% Stock Surge Over Past Year

2025-11-12 15:26:56

Theravance Biopharma, Inc. has recently undergone a revision in its score, reflecting its impressive performance metrics and strong market position. The stock has outperformed the S&P 500 significantly over the past year and reported substantial growth in net sales and operating cash flow, indicating robust operational strength.

Is Theravance Biopharma, Inc. technically bullish or bearish?

2025-11-05 11:23:26

As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The MACD is bullish on both weekly and monthly time frames, while Bollinger Bands also indicate a bullish stance on both time frames. However, the monthly RSI shows a bearish signal, and the KST is mildly bearish on the weekly but bullish monthly. Moving averages are bullish on the daily. Dow Theory reflects a mildly bullish stance on both weekly and monthly. In terms of performance, Theravance Biopharma has outperformed the S&P 500 significantly year-to-date with a return of 56.75% compared to the S&P 500's 16.30%, and over the past year, it has returned 79.00% versus the S&P 500's 19.89%. Overall, the current technical stance is bullish, driven by strong MACD and Bollinger Bands indicators, despite some mixed signals from RSI and KST....

Theravance Biopharma Hits New 52-Week High of $15.34, Up 74.94%

2025-11-04 17:59:01

Theravance Biopharma, Inc. achieved a new 52-week high of USD 15.34 on November 3, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported significant growth in net sales and operating cash flow, alongside high institutional holdings, indicating robust operational fundamentals and a positive recovery trajectory.

Is Theravance Biopharma, Inc. technically bullish or bearish?

2025-11-04 11:35:14

As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by bullish signals in both the weekly and monthly MACD, as well as bullish Bollinger Bands across the same time frames. The daily moving averages also indicate a bullish trend. However, the monthly RSI shows a bearish signal, and the KST is mildly bearish on the weekly but bullish on the monthly, which suggests some mixed signals. In terms of performance, the stock has outperformed the S&P 500 significantly over the past year, returning 84.71% compared to the S&P 500's 19.89%. Over the year-to-date period, the stock has returned 61.74% versus the S&P 500's 16.30%....

Is Theravance Biopharma, Inc. technically bullish or bearish?

2025-11-03 11:34:51

As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by daily moving averages and positive signals from Bollinger Bands and KST on both weekly and monthly time frames. However, the MACD indicates a mildly bearish position on the weekly chart, and the RSI shows a bearish signal on the monthly chart. Dow Theory presents a mildly bearish view on the weekly but is mildly bullish monthly. In terms of performance, the stock has outperformed the S&P 500 over the past year with a return of 77.91% compared to the S&P 500's 19.89%, although it has underperformed over the 3-year and 5-year periods....

Is Theravance Biopharma, Inc. technically bullish or bearish?

2025-11-02 11:19:10

As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by daily moving averages and bullish signals from Bollinger Bands and KST across both weekly and monthly time frames. However, the MACD is mildly bearish on the weekly and bullish on the monthly, while the RSI shows a bearish signal on the monthly. Dow Theory indicates a mildly bearish weekly trend but a mildly bullish monthly trend. In terms of performance, the stock has outperformed the S&P 500 significantly year-to-date with a return of 55.79% compared to 16.30%, and over the past year with 77.91% against 19.89%. However, over the longer term, the 3-year and 5-year returns are lagging behind the S&P 500. Overall, the current technical stance is bullish but with some mixed signals in the indicators....

Is Theravance Biopharma, Inc. technically bullish or bearish?

2025-10-28 11:44:18

As of 24 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, and the moving averages are bullish on a daily basis. Additionally, the Bollinger Bands are bullish weekly and mildly bullish monthly, while the KST is bullish in both time frames. However, the RSI shows a bearish signal on the monthly chart, indicating some caution. The Dow Theory is mildly bullish monthly but shows no trend weekly. The OBV is mildly bullish weekly but mildly bearish monthly, suggesting mixed volume trends. Overall, the strength of the bullish stance is supported by multiple indicators, despite some mixed signals. No multi-period return data is available for comparison with the S&P 500....

Is Theravance Biopharma, Inc. technically bullish or bearish?

2025-10-27 11:55:26

As of 24 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators from the MACD and KST on both weekly and monthly timeframes. The moving averages are also bullish on the daily timeframe. However, the RSI shows a bearish signal monthly, indicating some caution. The Bollinger Bands are bullish weekly and mildly bullish monthly, while the Dow Theory indicates a mildly bullish trend monthly. Overall, the strength of the bullish stance is supported by multiple indicators, despite some mixed signals from the RSI and OBV. Multi-period return data is not available for comparison with the S&P 500....

View All News